842 results
Page 2 of 43
CORRESP
bpq4clz
26 Oct 22
Correspondence with SEC
12:00am
8-K
EX-99.1
fbi16ppe0l
26 Jul 22
Key financial highlights and outlook
4:56pm
8-K
EX-3.1
ez9s vuvf8fhh
23 Jun 22
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
EX-99.1
d8t504uz556s 1mjpv0
3 May 22
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
uirpx809hchfaf6ljb2
9 Feb 22
Results of Operations and Financial Condition
7:00am
8-K
EX-5.3
gez kr3b4pxmo
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-4.2
1xw tkiqhunf8vh
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-4.6
84zp2di hu
10 Nov 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-1.1
5vy1 gy2zb
4 Nov 21
Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,000,000,000 of Sustainability-Linked Senior Notes
4:44pm
424B5
2qqghckytny9wm719
4 Nov 21
Prospectus supplement for primary offering
4:41pm
8-K
jm3m xvi69rf
2 Nov 21
Other Events
6:10am
424B3
n1l j8qje
27 Oct 21
Prospectus supplement
8:51am
S-3ASR
ouoj6m542 p1sd1a3yjv
27 Oct 21
Automatic shelf registration
7:42am